» Articles » PMID: 19689375

ITK Inhibitors in Inflammation and Immune-mediated Disorders

Overview
Specialty Chemistry
Date 2009 Aug 20
PMID 19689375
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-2-inducible T cell kinase (ITK) is a non-receptor tyrosine kinase expressed in T cells, NKT cells and mast cells which plays a crucial role in regulating the T cell receptor (TCR), CD28, CD2, chemokine receptor CXCR4, and FcepsilonR-mediated signaling pathways. In T cells, ITK is an important mediator for actin reorganization, activation of PLCgamma, mobilization of calcium, and activation of the NFAT transcription factor. ITK plays an important role in the secretion of IL-2, but more critically, also has a pivotal role in the secretion of Th2 cytokines, IL-4, IL-5 and IL-13. As such, ITK has been shown to regulate the development of effective Th2 response during allergic asthma as well as infections of parasitic worms. This ability of ITK to regulate Th2 responses, along with its pattern of expression, has led to the proposal that it would represent an excellent target for Th2-mediated inflammation. We discuss here the possibilities and pitfalls of targeting ITK for inflammatory disorders.

Citing Articles

Cytokines reprogram airway sensory neurons in asthma.

Crosson T, Bhat S, Wang J, Salaun C, Fontaine E, Roversi K bioRxiv. 2024; .

PMID: 39345572 PMC: 11429693. DOI: 10.1101/2023.01.26.525731.


The kinase ITK controls a Ca-mediated switch that balances T17 and T cell differentiation.

Anannya O, Huang W, August A Sci Signal. 2024; 17(846):eadh2381.

PMID: 39042726 PMC: 11445781. DOI: 10.1126/scisignal.adh2381.


Dihydroartemisinin inhibits follicular helper T and B cells: implications for systemic lupus erythematosus treatment.

Shi X, Liao T, Chen Y, Chen J, Liu Y, Zhao J Arch Pharm Res. 2024; 47(7):632-644.

PMID: 38977652 DOI: 10.1007/s12272-024-01505-1.


SARS-CoV-2, periodontal pathogens, and host factors: The trinity of oral post-acute sequelae of COVID-19.

Schwartz J, Capistrano K, Gluck J, Hezarkhani A, Naqvi A Rev Med Virol. 2024; 34(3):e2543.

PMID: 38782605 PMC: 11260190. DOI: 10.1002/rmv.2543.


ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas.

Jiang B, Weinstock D, Donovan K, Sun H, Wolfe A, Amaka S Cell Chem Biol. 2023; 30(4):383-393.e6.

PMID: 37015223 PMC: 10151063. DOI: 10.1016/j.chembiol.2023.03.007.


References
1.
Colgan J, Asmal M, Neagu M, Yu B, Schneidkraut J, Lee Y . Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk. Immunity. 2004; 21(2):189-201. DOI: 10.1016/j.immuni.2004.07.005. View

2.
Woods M, Kivens W, Adelsman M, Qiu Y, August A, Shimizu Y . A novel function for the Tec family tyrosine kinase Itk in activation of beta 1 integrins by the T-cell receptor. EMBO J. 2001; 20(6):1232-44. PMC: 145515. DOI: 10.1093/emboj/20.6.1232. View

3.
Khurana D, Arneson L, Schoon R, Dick C, Leibson P . Differential regulation of human NK cell-mediated cytotoxicity by the tyrosine kinase Itk. J Immunol. 2007; 178(6):3575-82. DOI: 10.4049/jimmunol.178.6.3575. View

4.
Brazin K, Fulton D, Andreotti A . A specific intermolecular association between the regulatory domains of a Tec family kinase. J Mol Biol. 2000; 302(3):607-23. DOI: 10.1006/jmbi.2000.4091. View

5.
Kawakami Y, Yao L, Tashiro M, Gibson S, Mills G, Kawakami T . Activation and interaction with protein kinase C of a cytoplasmic tyrosine kinase, Itk/Tsk/Emt, on Fc epsilon RI cross-linking on mast cells. J Immunol. 1995; 155(7):3556-62. View